PGNX

Progenics Pharmaceuticals Inc
PGNX

Delisted

PGNX was delisted on the 19th of June, 2020.

153 hedge funds and large institutions have $341M invested in Progenics Pharmaceuticals Inc in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
153
Holders Change
+11
Holders Change %
+7.75%
% of All Funds
3.47%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
27
Increased
48
Reduced
47
Closed
16
Calls
$1.37M
Puts
$2.36M
Net Calls
-$996K
Net Calls Change
-$23K
Name Holding Trade Value Shares
Change
Shares
Change %
Walleye Trading
151
Walleye Trading
New York
$50 +$50 +8,448 New
GC
152
Guggenheim Capital
Illinois
-$2.1M -285,574 Closed
VEA
153
Virtus ETF Advisers
New York
-$1.1M -148,929 Closed
SO
154
STRS Ohio
Ohio
-$577K -78,400 Closed
NFA
155
Nationwide Fund Advisors
Ohio
-$283K -38,428 Closed
GAM
156
Gotham Asset Management
New York
-$248K -33,737 Closed
Capital Fund Management (CFM)
157
Capital Fund Management (CFM)
France
-$181K -24,600 Closed
AP
158
AHL Partners
United Kingdom
-$147K -19,919 Closed
AQR Capital Management
159
AQR Capital Management
Connecticut
-$133K -18,012 Closed
MAM
160
Morse Asset Management
Connecticut
-$113K -15,400 Closed
SG Americas Securities
161
SG Americas Securities
New York
-$107K -14,530 Closed
PI
162
PineBridge Investments
New York
-$64K -8,721 Closed
AFNAS
163
American Financial Network Advisory Services
California
-$2K -220 Closed
AIM
164
Advantage Investment Management
Iowa
-$1K -100 Closed